Shareholders' Deficit (Details) - Schedule of Activity Related to Non-Vested Shares - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Schedule of Activity Related to Non-Vested Shares [Abstract] | ||
| Number of Non-Vested Shares, beginning balance | 16,970,120 | 14,270,120 |
| Weighted Average Grant Date Fair Value, beginning balance | $ 0.119 | $ 0.14 |
| Number of Non-Vested Shares, Granted | 3,500,000 | |
| Weighted Average Grant Date Fair Value, Granted | $ 0.014 | |
| Number of Non-Vested Shares, Shares vested | (2,000,000) | (800,000) |
| Weighted Average Grant Date Fair Value, Shares vested | $ (0.021) | $ (0.037) |
| Number of Non-Vested Shares, ending balance | 14,970,120 | 16,970,120 |
| Weighted Average Grant Date Fair Value, ending balance | $ 0.132 | $ 0.119 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Number of options vested. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|